The BRAzil MAGnesium (BRAMAG) trial: a randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity

BACKGROUND: Preterm birth is the leading cause of infant mortality globally, including Brazil. We will evaluate whether oral magnesium citrate reduces the risk of placental dysfunction and its negative consequences for both the fetus and mother, which, in turn, should reduce the need for indicated p...

Descripción completa

Detalles Bibliográficos
Autores principales: Alves, Joao Guilherme B, de Araújo, Carla Adriane Fonseca Leal, Pontes, Isabelle E A, Guimarães, Angélica C, Ray, Joel G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096428/
https://www.ncbi.nlm.nih.gov/pubmed/25005784
http://dx.doi.org/10.1186/1471-2393-14-222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096428/
https://www.ncbi.nlm.nih.gov/pubmed/25005784
http://dx.doi.org/10.1186/1471-2393-14-222

Ejemplares similares